VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1221644
Sex: F
Age:
State: AZ

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: my daughter and I had itchy eyes; This is a spontaneous report from a contactable physician. This physician reported for two patients. This is 2 of 2 report. A 38-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Arm Left on 26Jan2021 09:00 (Batch/Lot Number: EL9263) as SINGLE DOSE for covid-19 immunization. The patient is small, not overweight, a little on the skinny side. Patient medical history was none. Family medical history was none. There were no concomitant medications. The patient did not receive any prior vaccinations within 4 weeks. AEs follow prior vaccinations was none. Additional vaccines administered on same date of pfizer suspect was none. History of all previous immunizations was not provided. It was reported that caller, her daughter, and her husband, all received the first dose of the Pfizer COVID vaccine on 26Jan2021. Caller and her daughter experienced very itchy eyes on 27Jan2021-28Jan2021. It then subsided. Asked if this is an allergic reaction and would it interfere with getting the second dose. If it is an allergic reaction, would there be a worse allergic reaction to the second dose, which is scheduled for 26Feb2021. Has the same question for her daughter too. The reporter was concerned if it plays an relevance to the second COVID shot. The patient frequently takes care of the caller, who is 79, and caller's husband, who is 84. On that basis was offered the COVID Vaccine. The AEs did not require visit. Relevant tests was none. Investigation Assessment was none. The event was assessed as insignificant. Relatedness assessment of drug to event by unspecified company was unknown. Outcome of the event was recovered on 28Jan2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021116744 same reporter/drug/AE, different patient.

Other Meds:

Current Illness:

ID: 1221645
Sex: M
Age:
State: MA

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: chills; rapid heartbeat 175+/rapid heartbeat; bad rash on torso; fever 100.0 f; nausea; brutal headache; muscle pain; tired; This is a spontaneous report from a contactable consumer (Patient). A 68-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number EM9551), via an Intramuscular route of administration in left arm on 12Feb2021 10:06 at single dose for COVID-19 immunization. Patient medical history known allergies: Penecillin, Seasonal allergy, hay fever, and COVID. Past Drug Event included Aspirin and Tylenol for Known allergies. Concomitant medication included flonase allergy relief for allergies, atorvastatin, tadalafil, prilosec, and elder flower. He had a bad rash all over his torso 12 hours in. He clarifies later the rash could have been almost 24 hours after the injection. The rash has slightly improved. The caller also experienced a very rapid heartbeat of about 177. He also had a fever for about 24 hours. Caller states his rapid heartbeat was consistent with the fever and chills. He confirms these symptoms started about 12 hours after receiving the injection. Patient underwent lab test and procedural included Body temperature 100.0 Fahrenheit, Heart rate 177.The outcome of the events was recovering. No follow-up attempts are needed. No further information is expected

Other Meds: FLONASE ALLERGY RELIEF; ATORVASTATIN; TADALAFIL; PRILOSEC [OMEPRAZOLE MAGNESIUM]; ELDER FLOWER

Current Illness:

ID: 1221646
Sex: F
Age:
State: FL

Vax Date: 02/15/2021
Onset Date: 02/16/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: felt like a mad truck had hit her/she feels horrible; low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: EL9267, Expiration date: unknown) via an unspecified route of administration on 15Feb2021 at single dose for COVID-19 Immunization. Patient medical history included Covid in last October. Concomitant medication was not reported. Patient stated that she already spoke to a Nurse about the side effects she experienced before she was transferred . The patient reported that she received first dose of the vaccine yesterday and at first, she felt fine but on 16Feb2021 when she woke up, she felt like a mad truck had hit her. The patient also had low-grade fever; it was very unusual for her as she usually an energetic person. Patient took lowest dose of Tylenol for events and was not sure whether it was ok to take any medications with the vaccine since she saw some add on TV about the side effects. The patient added that she was expected to experience these side effects after taking her second dose of the vaccine not after first dose. Also wanted to know if the side effects she experienced right now could possibly be related with her having Covid last October. Patient also reported that she disappointed with the information provided to her, as she expected little bit more help. The patient wanted to have information on the effects of the vaccine on people who previously had Covid. Patient confirms saw the Pfizer COVID 19 vaccine. She also saw the batch number EL9267. She does not see and expiration date or NDC number. Patient went to bed after her vaccination and she felt fine, life was normal but when she woke up this morning, she felt horrible. The product complaint was reported. The outcome for the events was unknown. Upon follow-up on 16Feb2021: This is a follow-up spontaneous report from a contactable consumer included Patient age, weight, height, lot number of suspect products, events with onset date. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1221647
Sex: M
Age:
State: NY

Vax Date: 01/25/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: had me take a week of anti-viral medication. I am wondering whether that medication interfered with the efficacy of the vaccination; developed shingles; This is a spontaneous case is received reported from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration on 25Jan2021 as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication not reported. The patient experienced developed shingles, had me take a week of anti-viral medication. I am wondering whether that medication interfered with the efficacy of the vaccination. The outcome of event was unknown

Other Meds:

Current Illness:

ID: 1221648
Sex: M
Age:
State: NC

Vax Date:
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: painful injection site; This is a spontaneous report received from a contactable male physician (patient himself) of an unspecified age received first dose of BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot number/Expiry date: unknown) via an unspecified route of administration and second dose received(lot number: unknown) via an unspecified route of administration on unspecified date both as single dose for covid-19 immunisation. Patient's medical history and Concomitant medications were not reported. The patient experienced painful injection site due to administration technique used by nurse, "long needle and unusually painful injection site." Safety Concern Reported it as an adverse Event, which was non serious.The outcome of the event was unknown. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1221649
Sex: F
Age:
State:

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: exposed to COVID 19; This is a spontaneous report from a contactable consumer. This consumer reported similar events for two patients (Herself and her partner). This is 1st of two reports. A 70-years-old female patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 28Jan2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. It was reported that she and her partner received their first dose of the Pfizer COVID vaccine on 28Jan2021. Caller states they are both scheduled to receive their second dose on 18Feb2021. Caller states on this past Saturday night her granddaughter was there with them and she left this morning and her daughter called her and told her that somebody at her office tested positive for COVID. Caller states that someone who had tested prior and was negative also tested positive for COVID. Caller states she was unsure if her granddaughter being present in the house has exposed them to the virus. Caller would like to know if she should receive the second dose of the vaccine on 18Feb2021 if she was exposed to COVID 19. Outcome of the event was unknown. Information on the lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021201340 Same Vaccine/event, different patient

Other Meds:

Current Illness:

ID: 1221650
Sex: F
Age:
State: TN

Vax Date: 03/05/2021
Onset Date: 03/01/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Slight arm soreness and headache; Slight arm soreness and headache; This is a spontaneous report from a Pfizer-sponsored program . A contactable consumer reported similar events for 2 patients. This is 1st of 2nd report. A 73-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 05Mar2021 02:30 (Batch/Lot Number: EN6200) as single dose for covid-19 immunization. The patient's medical history and concomitant medica-tions were not reported. He took her dose 1 Caller, and her husband had the first dose via an un-specified route of administration, administered in Arm Right (Batch/Lot Number: EN6200) as sin-gle dose for covid-19 immunization. Caller and her husband had the first dose vaccine on 12Feb and are scheduled to have the second dose on 12Feb2021 2:15 She called the vaccination site and they told her that they could only be given the vaccine at the end of Mar. She is concerned since it will be 6 weeks after the first dose rather than 3 weeks. Is it ok. Had the first dose on 12Feb2021 and scheduled to get the second dose on 15Mar2021 but the caller stated that she tried to call the facility to confirm it, but the available date for her to take the second dose will be by the end of Mar as per the Facility. Caller and her husband had the first dose of the vaccine. she stated that her husband and herself both got the shot on the same day and experienced slight arm soreness and headache on Mar2021. The outcome of the events was recovered on Mar2021 No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : PFIZER INC-2021201092 Same Vaccine/event, different patient

Other Meds:

Current Illness:

ID: 1221651
Sex: F
Age:
State: NE

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: headache; fatigue; This is a spontaneous report from a contactable consumer (patient) reported in response to Non-HCP follow-up letter sent in cross reference case. A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: EK7176) second dose via an intramuscular, administered in right arm on 08Jan2021 at 15:50 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received the first dose of PFIZER-BIONTECH COVID-19 VACCINE on 18Dec2020 at 15:50 (Batch/Lot no: EH9899) as single dose for COVID-19 immunization and experienced headache and fatigue. On 09Jan2021 at 08:00, the patient experienced headache and fatigue. The patient reported that the events recur on re-administration of product and provided the time lag from stop date as 12 hours post 2nd injection. The reporter considered a reasonable possibility that the event is related to suspect product. The outcome of the events was recovered.

Other Meds:

Current Illness:

ID: 1221652
Sex: F
Age:
State:

Vax Date: 01/26/2021
Onset Date: 02/01/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: in a contact with a distant relative who tested positive to COVID-19; cough; sore throat; This is a spontaneous report from a contactable consumer (Patient). A 24-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 26Jan2021 (Batch/Lot Number: EL3248) as single dose for COVID Prevention (age at vaccination was 24 years). She does have regular allergies, her whole family does, so she gets sick easily and it is not abnormal for her. She had no other vaccines on the same days as her doses of the COVID vaccine. Patient received concomitant therapy. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 05Jan2021 (Batch/Lot Number: EL1284) as single dose for COVID-19 immunisation (age at vaccination was 24 years). The patient reported that She explained she was in a contact with a distant relative who tested positive to COVID-19 therefore, she got tested for COVID-19 and spent 10 days in quarantine. She specified her test result came back "inconclusive". She works at a shelter service. Patient got her second dose of the COVID vaccine on 26Jan2021, and last week, patient's husband received a text from his daughter's mom, saying that their house has tested positive for COVID. Patient's husband is in healthcare. They were both fully vaccinated, but her worker put her on quarantine. She went to get tested for COVID on Tuesday of last week and her husband tested negative but her test was inconclusive. Patient stated that a couple days after she got the COVID test, she started with a cough and sore throat on an unknown date in Feb2021 and she had that for a few days. She did also develop a cough and sore throat for a few days following her COVID test. She had her COVID test on 09Feb2021 and it came back inconclusive, she indicated it was not a rapid test, but she does not know the official name for the test she got, it was a drive through nasal swab test. Outcome of events cough and sore throat was recovered on an unknown date in Feb2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1221653
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: she experienced pain on the right arm after the first dose.; This is a spontaneous report from a contactable female consumer via Pfizer-sponsored program. A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2 Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as SINGLE DOSE for as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, she experienced pain on the right arm after the first dose. (pain in extremity). The Caller is scheduled for her second dose on the 22Feb and asking if it's safe to take Tylenol for the fever. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1221654
Sex: M
Age:
State: MD

Vax Date: 01/14/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: had swelling around left nipple area; had tenderness around left nipple area; This is a spontaneous report from a contactable consumer (patient). An 83-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EL03249, NDC number: Unknown, Expiry Date: Unknown) via an unspecified route of administration on 14Jan2021 at 10:40 in left arm as a single dose for covid-19 immunization. Patient received the second dose on 4Feb2021. There was no medical history reported. There was no history of previous immunization with the Pfizer vaccine. Patient did not take any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. There were no AE following prior vaccinations. Caller wanted to report a side effect from his first Pfizer dose. After 2-3 weeks the first dose, patient had swelling around the left nipple area and tenderness and wanted to know if this was a side effect. Clarified that it is for the Pfizer Covid 19 shot. AE did not require a visit to Emergency Room/Physician Office. There were no relevant tests done. Outcome of the event swelling around left nipple area was recovering while that of tenderness around left nipple area was unknown.

Other Meds:

Current Illness:

ID: 1221655
Sex: M
Age:
State: OH

Vax Date: 02/13/2021
Onset Date: 02/14/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Supraclavicular lymphadenopathy noticed; Generalized blanching rash covering thighs abdomen chest and arms,around 24 hours after the second dose resolved within a day; This is a spontaneous report from a contactable Physician (patient) A 32-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot No: unknown, expiration date: unknown) via an unspecified route of administration anatomical location Left arm on 13-FEB-2021 12:45 at single dose for COVID-19 immunization. Patient historic vaccine include first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot No: unknown, expiration date: unknown) via an unspecified route of administration anatomical location Left arm on 23Jan2021,10:30 at single dose for COVID-19 immunization. medical history included Autoimmune urticaria. concomitant medication include Antihistamine. On 14Feb2021 13:00 patient experienced Generalized blanching rash coveringthighs abdomen chest and arms, around 24 hours after the second dose resolved within a day.Supraclavicular lymohadenopathy noticed 72 hours after. patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any treatment for the event. Prior and post to the vaccination, the patient was not diagnosed with COVID-19. patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any treatment for the event. Prior and post to the vaccination, the patient was not diagnosed with COVID-19.The outcome of event was Recovering/Resolving. Information on the lot/batch number has been requested

Other Meds:

Current Illness:

ID: 1221656
Sex: F
Age:
State: FL

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Headache; Chills; Tired; Itching; Swelling at site of filler; This is a spontaneous report received from a contactable consumer (reporting on herself). A 68-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Formulation: Solution for injection, lot number: el9262 and Expiry date was not reported), via an unspecified route of administration in Arm Left on 28Jan2021 09:30 as single dose for COVID-19 immunization. Medical history included Very Slight to shrimp and other shellfish, other medical history none. The historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246), in Left Arm on 07Jan2021 09:30 for COVID-19 immunization. Concomitant medication(s) included thyroid (ARMOUR THYROID); bupropion hydrochloride (WELL-BUTRIN) both taken for an unspecified indication, start and stop date were not reported. Patient did not have covid prior vaccination. Patient did not receive vaccine in four weeks. It was reported that patient experienced headache, chills, Tired, Itching-Swelling at site of filler-tired. The patient did not received any treatment for adverse events. Patient was not tested covid-19 post vaccination. The outcome of the events was recovered on an unspecified date.

Other Meds: ARMOUR THYROID; WELLBUTRIN

Current Illness:

ID: 1221657
Sex: F
Age:
State: TX

Vax Date:
Onset Date: 02/10/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: throat was itching; Tested positive for virus 10 days after receiving 1st dose.; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received first of BNT162B2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration on unspecified date at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported.On 10Feb2021,The patient tested positive for virus 10 days after receiving 1st dose and her throat was itching.The patient underwent lab tests and procedures which included SARS-CoV-1 test:positive on 10Feb2021. The outcome of events were unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1221658
Sex: M
Age:
State:

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Patient received the Pfizer-BioNTech COVID-19 Vaccine first dose last 28JAN2021 but got COVID-19; Patient received the Pfizer-BioNTech COVID-19 Vaccine first dose last 28JAN2021 but got COVID-19; This is a spontaneous report from a contactable pharmacist from Pfizer sponsored program. A 82-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 28Jan2021 (at 82-years age) as SINGLE DOSE for covid-19 immunization. The patient medical history was and concomitant medications were not reported. After receiving the Pfizer-BioNTech COVID-19 Vaccine first dose last 28JAN2021 patient got COVID-19 and asked when was it recommended for him to get their second dose. Caller mentioned she was advised to transfer. Offered transfer and Caller accepted. Unsuccessful transfer due to long hold time. Caller preferred the online safety reporting tool instead. Call transferred. Pharmacist. Has questions about covid vaccine. Wants to know on when antibodies go into system. And if patients get 1st dose of covid vaccine and then test positive for covid virus when do they received 2nd dose. Clarified if knows anyone who has tested positive after 1st dose, said yes but unsure if it was Pfizer or Moderna vaccine, also doesn't know anyone with antibody issue or needing testing. Relayed number. Cold transferred due to hold time. Will fax into. 159558. The outcome of the events was unknown. Information on the lot/batch number has been requested. Follow up (17Feb2021): This is a spontaneous report received from Pfizer sponsored program. A contactable pharmacist reported no new reported for patient.; Sender's Comments: Based on the information provided, the causality between the event and the suspect drug cannot be excluded.

Other Meds:

Current Illness:

ID: 1221659
Sex: F
Age:
State: FL

Vax Date: 02/09/2021
Onset Date: 02/11/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Test positive for Covid-19; Test positive for Covid-19; This is a spontaneous report from a contactable consumer (patient herself). An 84-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: E11284 and expiration date was not reported) via an unspecified route of administration in arm on 09Feb2021 and first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: E11284 and expiration date was not reported) via unspecified route of administration in right arm on 19Jan2021 both as single dose for COVID-19 immunisation. The patient medical history included allergy to morphine and adhesive. Concomitant medications were not reported. The patient was on other medications within two weeks prior to vaccination. Patient did not take other vaccine within four weeks prior to vaccination. On 11Feb2021 the patient tested positive for Covid-19. The patient did not have covid prior to vaccination and had tested for covid post vaccination. The patient underwent lab test which included SARS-COV-2-PCR on 11Feb2021 and results positive. The outcome of the event was unknown. Follow-up (17Feb2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported for a patient (mother) that: Caller submitted her mother's information and where it was given online. The lot number on the card is E11284 or EL1284 or EI1284. Given on 19Jan2021 and the second one was given on 09Feb2021. Information about lot and batch number was requested

Other Meds:

Current Illness:

ID: 1221660
Sex: F
Age:
State: FL

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: sleepy; cold; achy; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female (Non pregnant) patient received first dose of BNT162B2 (Pfizer COVID-19 vaccine, formulation: Solution for injection, lot number: EN6201, Expiration date; unknown), in the left arm on 15Feb2021 at 15:00 pm, at a single for COVID-19 immunization at doctor's office/urgent care. Patient medical history included unspecified chronic health conditions. Patient concomitant medication was not reported. Patient took unspecified other medications in two weeks. Patient had known allergies. On 15Feb2021 at 17:00 PM, the Patient became very sleepy had cold and achy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Events were not treated. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the post vaccination. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 1221661
Sex: M
Age:
State: FL

Vax Date: 01/14/2021
Onset Date: 02/04/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: his arm is hurting; he experienced injection site discomfort during administration of the vaccine; This is a spontaneous report from a contactable consumer or other non-healthcare professional via Medical Information Team. An 87-years-old male patient (Husband) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL1283) via an unspecified route of administration in left arm on 14Jan2021 and second dose on BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL8982) via an unspecified route of administration in left arm on 04Feb2021 at 17:30 both as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 04Feb2021 05:30 pm, the patient experienced injection site discomfort during administration of the vaccine and on an unspecified date, patient experienced his arm is hurting. Reporter mentioned that the same thing happened on the first shot. Outcome of the events was resolved on unspecified date in 2021.

Other Meds:

Current Illness:

ID: 1221662
Sex: F
Age:
State: NE

Vax Date: 02/10/2021
Onset Date: 02/16/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: site pain; tiredness; headache; unwell/sour gut; chills w/out fever; This is a spontaneous report from a contactable consumer (patient). A 77-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6201), via an unspecified route of administration in left arm on 10Feb2021 at 11:45(at the age of 77-year-old ) as a single dose for COVID-19 immunization. Patient medical history included asthma, some mild arthritis, osteopenia. Concomitant medications included Mometasone Furoate(ASMANEX) (MANUFACTURER UNKNOWN), Esomeprazole sodium (NEXIUM) (MANUFACTURER UNKNOWN), Montelukast sodium (SINGULAIR) (MANUFACTURER UNKNOWN), (FLUTICASONE), vitamins. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. On 16Feb2021, on the 2nd and 3rd day, the patient experienced site pain, tiredness, headache. On the 6th day, the patient experienced chills without fever, tiredness, unwell/sourgut, headache. The outcome of the events was Recovered on an unknown date.

Other Meds: ASMANEX; NEXIUM [ESOMEPRAZOLE SODIUM]; SINGULAIR; FLUTICASONE

Current Illness:

ID: 1221663
Sex: F
Age:
State: WI

Vax Date: 01/01/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: borderline crazy; This is a spontaneous report from a contactable consumer (Patient). A 92-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL8982) via an unspecified route of administration in Arm Left on an Unspecified date in Jan2021 as single dose for covid-19 immunisation. Patient did not take other vaccine within 4 weeks prior of vaccination. Medical history included and concomitant medications. The patient experienced borderline crazy. The patient underwent lab tests which included weight: pounds is close enough. The outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 1221664
Sex: F
Age:
State: MI

Vax Date: 01/12/2021
Onset Date: 04/05/2020
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Sore arm; nausea; Headache; currently breastfeeding; This is a spontaneous report from a contactable Nurse. A 32-year-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Deltoid Left (at the age of 33-year-old) on 12Jan2021 12:55 (Batch/Lot Number: ET1685) at single dose for covid-19 immunisation. Medical history included herpes simplex from 01May2008 (Ongoing outbreak unknown year, exacerbated with viral infections), viral infection from 19Dec2020 to 01Jan2021 (I was COVID negative 21Dec2020), oropharyngeal pain from 19Dec2020 to 01Jan2021 (I was COVID negative 21Dec2020), nasal congestion from 19Dec2020 to 01Jan2021 (I was COVID negative 21Dec2020), breast feeding from 05Apr2020 to an unknown date (no change in breastfeeding frequency or output). Historical vaccine included BNT162B2 for Covid-19 immunization. Concomitant medication(s) included docosahexaenoic acid (DHA) from 03Aug2019 to an unspecified date; ibuprofen and paracetamol (TYLENOL). The patient reported, She had a viral infection (day 3) during my first dose of the vaccine (22Dec2020). She believed this exacerbated the expected side effects of vaccination. Her body needed extra care to recover. Her second vaccine was much easier to recover from. The patient experienced, On 05Feb2021, currently breastfeeding, on 12Jan2021, sore arm, nausea and headache. The patient underwent lab tests and procedures which included sars-cov-2 test negative on 21Dec2020. Therapeutic measures were taken as a result of events. The outcome of event for headache was recovering, for breastfeeding it was unknown and for the rest of the events it was recovered. Amendment: This follow-up is being submitted to amend the previous reported information which included: removed at-risk classification in the general tab.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020510892 Same reporter/ drug and different events/patients.

Other Meds: DHA; IBUPROFEN; TYLENOL

Current Illness:

ID: 1221665
Sex: F
Age:
State: NJ

Vax Date: 01/06/2021
Onset Date: 02/11/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: second dose on 27Jan. Caller stated on 11Feb she was tested positive for covid.; second dose on 27Jan. Caller stated on 11Feb she was tested positive for covid.; This is a spontaneous report from a Pfizer-sponsored program via a contactable consumer . A 90 (age unit unknown) old female patient received first dose and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported) via unspecified route of administration on 06Jan2021 and 27Jan2021 respectively both at single dose for covid-19 immunization. Medical history and concomitant medications were not reported. Patient reported that she received her first dose of the Pfizer covid vaccine on the 6Jan2021, second dose on 27Jan2021 and 11Feb2021 she was tested positive for covid. She wanted to know if she can go see her family, will she be contagious after being quarantined for 10days. Reporter assessed the case as non-serious. There was no PQC present. The outcome of the events was unknown. Information on the lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1221666
Sex: F
Age:
State: MO

Vax Date: 02/04/2021
Onset Date: 02/05/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: low blood pressure for a few days; Lymph node swelling left side below collarbone; Mildly more tired; slight headache; slight chills; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 68-years-old Non-pregnant female patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EM9809, Expiry date: 30Jun2022) via an unspecified route of administration, administered in left arm on 04Feb2021 at 15:00 as SINGLE DOSE for covid-19 immunization. The patient medical history included atrial fibrillation, ventricular tachycardia, cardiac pacemaker insertion, essential hypertension. The patient was allergic to Propafenone 150mg critical, Penicillin, and related antibiotics i.e., Lincosin serious, sulfa drugs, Statins, any products with alcohol taken internally, MSG, asprin sensitivity (ears ring, nose red), antihistamine sensitivity. The patient's concomitant medications included metoprolol ER 50mg, losartan 50mg and furosemide 20mg. The patient did not take any other vaccine in 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. On 05Feb2021, the patient experienced, lymph node swelling left side below collarbone next day for several days, mildly more tired, slight chills and low blood pressure for a few days, slight headache and low. Due to events the patient had consulted physician (Doctor or other healthcare professional office/clinic visit). Events were not treated. The outcome of the events was recovered.

Other Meds: METOPROLOL; LOSARTAN; FUROSEMIDE

Current Illness:

ID: 1221667
Sex: F
Age:
State: CA

Vax Date: 02/10/2021
Onset Date: 02/14/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Rashes on the right side of my neck on the 4th day after the first dose of vaccine. This rash has gone worse the next day, going down the right side of my neck and also on my face, and forehead.; Rash is raised, red and some had small yellow pinpoint in the center that was very itchy .; Rash is raised, red and some had small yellow pinpoint in the center that was very itchy .; This is a spontaneous report from a contactable Nurse. This 65-year-old female (non-pregnant) nurse reported for herself she received first dose of BNT162B2 (solution for injection, lot number: EL1283, Expiration date; unknown), in right arm on 10Feb2021,13:00 pm at single dose for COVID-19 immunization. Patient medical history included Left Stage 3 Breast Cancer in Feb2020, mild hypertension. Concomitant medications included Losartan and Amlodipine, Vitamin C and D3.Patient had no known allergies. The patient was not tested for COVID-19 since the vaccination.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19.On 14Feb2021 06:00 am, the patient experienced rashes on the right side of my neck on the fourth day after the first dose of vaccine. This rash has gone worse the next day, going down the right side of my neck and on my face, and forehead. Rash is raised, red and some had small yellow pinpoint in the centre that was very itchy. Patient not received treatment for the events. Adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The outcome of the events was not recovered.

Other Meds: LOSARTAN; AMLODIPINE; VITAMIN C [ASCORBIC ACID]; VITAMIN D3

Current Illness:

ID: 1221668
Sex: M
Age:
State: NJ

Vax Date: 02/17/2021
Onset Date: 02/18/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Injection site pain; Body Ache; Tiredness/Exhaustion feeling; This is a spontaneous report from a contactable consumer (patient). A 54-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9266), via an unspecified route of administration in right arm on 17Feb2021 at 08:30 pm as single dose for COVID-19 immunization. The patient medical history included hypertension, blood cholesterol and overweight. There were no known allergies to patient. there was no COVID prior vaccination. The concomitant medications included metoprolol, simvastatin and amlodipine. On 18Feb2021, the patient experienced injection site pain, body ache, tiredness/exhaustion feeling. Patient did not receive any treatment for adverse event. There was no COVID tested post vaccination. It was reported that the patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: UNKNOWN) via an unspecified route of administration in right arm on 10Mar2021 at 08:15 am as single dose for COVID -19 immunization. The outcome of the events was not recovered. No follow-up attempts possible. No furthermore information expected.

Other Meds: METOPROLOL; SIMVASTATIN; AMLODIPINE

Current Illness:

ID: 1221669
Sex: F
Age:
State: KY

Vax Date: 01/29/2021
Onset Date: 02/01/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: a week later tested positive for COVID-19; This is a spontaneous report from a Pfizer-sponsored program by a contactable reporter (patient). A 27-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration date: Not available), via an unspecified route of administration on 29Jan2021 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. In Feb2021, a week after receiving the first dose, the patient was tested positive for COVID-19. The patients second dose is already due and would like to know if she is okay to get it or if there is a specific timeline that she should wait. The clinical outcome of the event COVID-19 was recovered. The patient underwent lab tests and procedures which included Covid test which was positive in Feb2021. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1221670
Sex: F
Age:
State:

Vax Date: 01/14/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: tested positive for Covid 19; tested positive for Covid 19; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 2 patients (Herself and husband). This is a 1st of 2 reports. This 70-year-old female consumer (patient) reported for herself. A 70-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: not reported) via an unspecified route of administration on 14Jan2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications was not reported. The caller says that she had her first vaccine shot and was ready to get her second shot but she got the COVID week after first dose in 2021. She says that she had her appointment for on the second, then on the first she tested positive. Caller says something about her husband and daughter two days later, and a week after. Unable to clarify with caller due to poor sound quality and caller speaking over call handler. She says her question was can she get the second dose of the vaccine still and how soon she can get it. She says her husband is 84, and she is 70, and they had very mild symptoms, so she thinks the vaccine helped them, which her daughter had it worse. The patient underwent lab tests and procedures which included sars-cov-2 test: positive. The outcome of the events was unknown Information about lot/batch has been requested. Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021180363 same reporter/vaccine/AE, different patients

Other Meds:

Current Illness:

ID: 1221671
Sex: F
Age:
State: WV

Vax Date: 02/06/2021
Onset Date: 02/06/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: felt very tired/became tired then more tired; was very cold/very cold for 6-7 hours; Chills; Lethargic; her temperature and it was 100.8; slept most of day; no appetite; pain where the shot was given; arm hurt more, it had hurt through the night; This is a spontaneous report from a contactable consumer. This 71-year-old female consumer reported that she received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an intramuscular route of administration, administered in Arm Left on 06Feb2021 10:15 (Batch/Lot Number: EM9810) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications was not reported. The patient experienced pain where the inoculation was given in the left upper arm started on that day but got worse the next day. She explains that the next day when she woke up at 7:30 am she felt ok but then at 10 am she felt very tired and noticed her arm hurt more, it had hurt through the night. She was very, very tired and then about 10:30 am she was very cold. She had fireplace and electric heater on plus had 2 blankets on her. She asked her husband to go to the car to get her winter gloves and she was wearing scarf. This lasted 6 hours before it resolved. Her husband took her temperature, and it was 100.8. It was reported that she had no appetite during the day. Upon follow-up (16Mar2021), was reported that, 24 hours after first dose of Pfizer chills started, become tired then more tired; then slept most of day. Fever occurred throughout the day topping at 100.3 and was very cold for 6-7 hours, with 2 blankets, scarf, winter gloves while lounging in front of fireplace, plus small electric heater. The patient underwent lab tests and procedures on unspecified date which included body temperature:100.8. The action taken in response to the events for bnt162b2 was not applicable. The outcome of the events injection site pain, nasopharyngitis, decreased appetite and upon follow-up the events chills, slept most of the day, lethargic, fever was recovered and outcome for fatigue was recovering and unknown for Pain in extremity. Follow-up (16Mar2021): this follow-up information was received from a contactable consumer and the new information reported includes, additional events was provided along with the onset date and time. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1221672
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Headache; This is a spontaneous report from a contactable consumer or other non hcp. A 76-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on unspecified date as single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication's included raloxifene hydrochloride (EVISTA), rosuvastatin calcium (CRESTOR) taken for an unspecified indication, start and stop date were not reported. Patient stated that she wanted to know if the drugs interact with the Pfizer Covid vaccine. Stated that the drugs she took were Evista and Crestor. Wanted to know if she could take an Excedrin if she got a headache the next day. Patient stated that she had one dose of the vaccine already and got a headache two days later. Stated she gets headaches in the morning anyway. Stated that she was not sure that the headache was from the vaccine. The outcome of the event was unknown. Information on lot/ batch number has been requested.

Other Meds: EVISTA; CRESTOR

Current Illness:

ID: 1221673
Sex: F
Age:
State: VA

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: existing auto immune condation; This is a spontaneous report from a contactable nurse (Patient). A 61-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer BioNTech, COVID 19, solution for injection, lot number: unknown, Expiration date; unknown), in right arm on 23Dec2020, 12:00 PM at single dose for COVID-19 immunization. Patient medical history included rheumatoid arthritis. Concomitant medications included losartan. Patient had allergies to penicillin. After the first vaccination patient noticed a slight change. Patient also had existing auto immune condition on 24Dec2020. Patient received steroids as treatment for adverse event. No other vaccine in four weeks. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination the patient had not been tested for COVID-19. The outcome of the events was not recovered.

Other Meds: LOSARTAN

Current Illness:

ID: 1221674
Sex: M
Age:
State:

Vax Date: 01/14/2021
Onset Date: 01/01/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: tested positive for Covid 19; tested positive for Covid 19; This is a spontaneous report from a contactable consumer (patient's wife). A 84-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in Jan2021, weeks after the first dose, the patient tested positive for COVID-19. The patient underwent lab tests and procedures which included sars-cov-2 test: positive. The reporter classified the event as non-serious. The outcome of the events was unknown. Information regarding Lot/Batch number has been requested. Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021178604 same reporter/vaccine/AE, different patients

Other Meds:

Current Illness:

ID: 1221675
Sex: U
Age:
State: IL

Vax Date: 02/09/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: fatigue; Sore arm; low appetite; This is a spontaneous report from a contactable consumer (patient) via Pfizer sales representative. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiry date were not reported), via an unspecified route of administration on 09Feb2021 as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, the patient fatigue, sore arm, and low appetite. Clinical outcome of the events was unknown. No follow up attempts are possible. Information about Lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1221676
Sex: M
Age:
State: CO

Vax Date: 02/03/2021
Onset Date: 02/13/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: tested positive for COVID-19; This is a spontaneous report from a contactable consumer (Patient) via Pfizer-sponsored program CEP/PSP ID: 159558. A 73-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE. Formulation: Solution for injection, Lot# UNKNOWN), via unspecified route of administration on 04Feb2021 (at the age of 73 years-old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 13Feb2021, patient tested positive for COVID-19. The patient underwent lab test which included SARS-COV-2 Test: Positive on 13Feb2021. Patient was told by the health department that he needs to remain in isolation for 10 days. Patient was scheduled for his second dose of the Pfizer COVID-19 vaccine on 25Feb2021 and would like to know if he will be able to receive his second dose of the Pfizer COVID-19 vaccine on the scheduled appointment date. Information of lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1221677
Sex: F
Age:
State: CA

Vax Date: 02/10/2021
Onset Date: 02/14/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Her results were negative; 'chills and fever' nonstop until today and it is getting worse; chill; This is a spontaneous report from a non-contactable consumer via medical information team. A 80-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, Lot number: not reported) via an unspecified route of administration on 10Feb2021 as single dose for covid-19 immunisation. On the night of 14Feb2021, the patient started to feel chills and fever nonstop until today and it was getting worse. The patient took a covid test, because during the week before the patient had been receiving physical therapy and they suspected that she had been infected. The results were negative. The doctor asked them to go to the ER for treatment. The patient did not lost taste or smell. The patient underwent lab tests and procedures which included oxygen levels have been between 95-97% and only once did it go down to 93%. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1221678
Sex: M
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: headache; nausea; fatigue; This is a spontaneous report from a contactable consumer. A 57-year-old male patient received the second dose BNT162B2 (Lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date (at the age of 57-year-old as reported) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced headache, nausea, and fatigue after receiving the second dose of the vaccine on unspecified date. The outcome of the events was unknown. No follow up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1221679
Sex: F
Age:
State: CA

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Shot 1 - left arm ached 2 days; 5 days later diarrhea for a few days; This is a spontaneous report from a contactable consumer. A 65-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 28Jan2021 01:15 PM (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. Medical history included osteoporosis, sleep apnoea, reflux. Concomitant medication included VITAMIN D [VITAMIN D NOS], Multi Vitamin and omeprazole (PRILOSEC [OMEPRAZOLE]) at once a day taken for an unspecified indication. It was reported that after Shot 1 in left arm ached 2 days, 5 days later diarrhea for a few days. Outcome of the events was recovered on unspecified date. Information on lot/batch number has been requested.

Other Meds: VITAMIN D [VITAMIN D NOS]; PRILOSEC [OMEPRAZOLE]

Current Illness:

ID: 1221680
Sex: M
Age:
State: TX

Vax Date: 02/03/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Indicates "got sick" after a week, wife SARs-Cov-2 positive. He was tested, also positive.; Indicates "got sick" after a week, wife SARs-Cov-2 positive. He was tested, also positive.; Indicates "got sick" after a week, wife SARs-Cov-2 positive. He was tested, also positive.; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 2 patients. This is 1st of two reports. A 70-year-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 03Feb2021 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported, he had his first shot on 03Feb2021 and scheduled for the second one on 25Feb2021. After a day, he kind of got sick for a whole week. He run a test, and came out to be positive, that was after one week of the shot. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021211673 same reporter, product and AE, different patient

Other Meds:

Current Illness:

ID: 1221681
Sex: F
Age:
State: GA

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: fever began with chills/temp of 100; sore arm; didn't feel well; fatigue; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot No: EL19581) via an unspecified route of administration in right arm on 10Feb2021 09:15 AM at single dose for COVID-19 immunization. Medical history included High blood pressure and moderate cholesterol. Patient has no known allergies. The patient was not pregnant. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included CRESTOR (rosuvastatin calcium) 10mg, losartan, ASA (acetyl salicylic acid) 81 mg, PROTINIX (omeprazole) 40mg (all received in two weeks). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot No: EL3249) in right arm on 27Jan2021 at single dose at the age of 74 years for COVID-19 immunization. The patient experienced extremely sore arm, didn't feel well and fever began with chills 12 hours after 2nd injection on 10Feb2021 at 09:15 AM. All night and next day, fever and fatigue treated with Tylenol and one Aleve taken mid day. She usually run a subnormal temp, so subnormal temp so a temp of 100 (unit not provided) was bothersome to her especially with chills. The patient was not diagnosed with COVID-19 post to vaccination. The outcome of events was recovered in 2021. Information about lot/ batch number has been updated.

Other Meds: CRESTOR; LOSARTAN; ASA; PROTONIX [OMEPRAZOLE]

Current Illness:

ID: 1221682
Sex: M
Age:
State: FL

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: arms were tingling; Temporary numbness in left hand.; This is a spontaneous report received from a contactable consumer (patient) reporting on himself. A 75-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: em9810), via an unspecified route of administration on 12Feb2021 09:45 (at the age of 75-year-old) as SINGLE DOSE in Right arm for covid-19 immunization. The patient had no relevant medical history and no known allergies and have no concomitant medications. The patient did not receive any other vaccine in four weeks. Prior to the vaccination, the patient had no covid infection. On 12Feb2021, the patient had temporary numbness in left hand, approximately in 20 minutes, his hand returned to normal after event. The patient couldn't do anything with his hand and his arm was not effected. It hasn't happened again, two days later, on 14Feb2021, the patient had second event. He woke up at 4:45 AM both fore arms were tingling between the wrist and elbow. The tingling was sufficient to wake him up. It only lasted around 15 minutes. It has not reoccurred. The patient did not receive any treatment for the events. Post vaccination, the patient was not tested for covid. The outcome of event hypoaesthesia was recovered on 12Feb2021 and the outcome of event paraesthesia was recovered on 14Feb2021 at 05:00.

Other Meds:

Current Illness:

ID: 1221683
Sex: M
Age:
State:

Vax Date: 02/20/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: kidneys and heart disease; kidneys and heart disease; This is a spontaneous report from a Pfizer-sponsored program . A contactable consumer (patient) reported that a male patient of an unspecified age (Age: 70; unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 20Feb2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced kidneys and heart disease on an unspecified date. Outcome of events was unknown. No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1221684
Sex: F
Age:
State: NY

Vax Date: 02/13/2021
Onset Date: 02/15/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: chills; Bad Headache; This is a spontaneous report from a contactable consumer(patient). A 76-year-old (non-pregnant) female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809 and Expiration Date: UNKNOWN), via unspecified route of administration in left arm on an 13Feb2021 09:45(at the age of 76-year-old) as a single dose for COVID-19 immunization. The patient medical history was not reported. Patient relevant medical history included, Sulfa Allergy, drug allergy (Amoxicillin). Other medical history reported as very good health. The patient was not diagnosed with COVID-19 prior to vaccination. Patient concomitant medications included in two weeks alendronate sodium (FOSAMAX) (MANUFACTURER UNKNOWN) on 15Feb, simvastatin (MANUFACTURER UNKNOWN), levothyroxine sodium (MANUFACTURER UNKNOWN). Headache and chills since 16Feb Take Advil every 6 hours to mitigate reaction. Was fine day after shot, Took Fosamax on 15Feb and chills and fatigue set in that PM. On 15Feb2021 at 19:00 the patient experienced bad Headache and chills. Headaches started on 16Feb and continue. Since 16Feb2021 patient took Advil every 6 hours to mitigate reaction. On 20Feb2021, Nasal Swab COVID test was performed post vaccination included, negative result. The outcome of the event was reported as not recovered.

Other Meds: FOSAMAX; SIMVASTATIN; LEVOTHYROXINE SODIUM

Current Illness:

ID: 1221685
Sex: M
Age:
State: FL

Vax Date: 02/22/2021
Onset Date: 02/01/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: After the 2nd dose my arm was very sore (muscle ache) and fever; After the 2nd dose my arm was very sore (muscle ache) and fever; My arm was very sore; The initial case was missing the following minimum criteria: identifiable patient. Upon receipt of follow-up information on 29Mar2021, this case now contains all required information to be considered valid. This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer (patient) reported that, A 82-years-old male patient received bnt162b2 (Pfizer-Biontech Covid-19 Vaccine, Solution for injection), dose 2 intramuscular, administered in Arm Left on 22Feb2021 15:30 (Batch/Lot Number: EN6201) as single dose for covid-19 immunisation. Medical history included ongoing COPD (chronic obstructive pulmonary disease) from 2000 and ongoing Enlarged Prostate from 2000. Historical vaccine included bnt162b2 (Pfizer-Biontech Covid-19 Vaccine, Lot number: EL5982) dose 1 Intramuscular, administered in Left Upper Arm on 02Feb2021 1:10 PM for COVID-19 immunisation. Concomitant medication included tiotropium bromide (SPIRIVA) taken for chronic obstructive pulmonary disease from 2000, salbutamol (ALBUTEROL HFA) taken for chronic obstructive pulmonary disease from 2000 and ongoing, budesonide, formoterol fumarate (SYMBICORT) taken for chronic obstructive pulmonary disease from 2000 and ongoing, terazosin (TERAZOSIN) taken for prostatomegaly from 2000 and ongoing and finasteride (FINASTERIDE) taken for prostatomegaly from 2000 and ongoing. The patient experienced after the 2nd dose my arm was very sore (muscle ache) and fever and my arm was very sore on an unspecified date in Feb2021. The patient underwent lab tests and procedures which included positron emission tomogram: unknown on 22Feb2021 Slightly radioactive spinal fluid culture. Outcome of the events was recovered on an unspecified date. No follow-up attempts are needed. No further information is expected.

Other Meds: SPIRIVA; ALBUTEROL HFA; SYMBICORT; TERAZOSIN; FINASTERIDE

Current Illness: COPD; Enlarged prostate

ID: 1221686
Sex: F
Age:
State: FL

Vax Date: 02/12/2021
Onset Date: 02/13/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: flu like symptoms; 100 degree temperature; Joint Ache; Nausea; migraine; This is a spontaneous report from a contactable consumer (patient). A 69-years-old female consumer received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EL9269and expiration date: Not available), via an unspecified route of administration in the right arm on 12Feb2021 at 09:45 AM as a single dose for COVID-19 immunisation. The patient was not pregnant. The patients medical history included lung cancer. The patient had sulpha-based medications allergy. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EL9263 and expiration date: Not available) via an unspecified route of administration in the right arm on 22Jan2021 at 15:30 PM. Prior to the vaccination, the patient was not diagnosed with COVID-19. No covid test post vaccination. No other vaccine in four weeks. The patient received Rosuvastatin, Vitamin D, Calcium, and daily multivitamins in two weeks. On 13Feb2021 at 19:00 PM, the patient experienced flu like symptoms, 100-degree temperature, joint aches, chills, nausea, and migraine. The patient did not receive any treatment for the events. The outcome of the event was recovered.

Other Meds: ROSUVASTATIN; VITAMIN D [COLECALCIFEROL]; CALCIUM

Current Illness:

ID: 1221687
Sex: F
Age:
State: MA

Vax Date: 01/26/2021
Onset Date: 02/19/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Bruising; Soreness and pain in left arm at site; Soreness and pain in left arm at site, under arm pit; Soreness and pain in left arm at site, under arm pit and around breast; This is a spontaneous report from a contactable other HCP (patient). A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 26Jan2021 (Batch/Lot Number: EL9261) as single dose for covid-19 immunisation (age at vaccination was 60 years). No other vaccine in four weeks and other medications in two weeks were reported. No Known allergies and no other medical history were reporter. Historical vaccine included dose 1 via an unspecified route of administration, administered in Arm Left on 05Jan2021 at 07:45 AM, (Batch/Lot Number: EK4176) as single dose for covid-19 immunisation (age at vaccination was 60 years). Following mammogram 26 days after (as reported) second dose the patient experienced bruising and soreness and pain in left arm at site, under arm pit and around breast on 19Feb2021 at 16:00. The patient recovered with lasting effects. No treatment was received for the events. No covid reported prior vaccination. Covid wasn't tested post vaccination. The patient underwent lab tests and procedures which included mammogram: unknown result. Outcome of events was recovered with sequelae on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1221688
Sex: F
Age:
State: NJ

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: My vaccine was at 2pm, that night I woke up around 4am with a fever; chills; headache; sore arm; This is a spontaneous report from a contactable Other HCP.A 30-years-old female patient (non-pregnant) received the second dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot noEL3247, Expiration date: unknown), via an unspecified route of administration in left arm on 10-FEB-2021 14:00 at single dose for COVID-19 immunization. Patient previously took first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot no. EL3247, Expiration date: unknown), via an unspecified route of administration in left arm on 22Jan2021 11:00 AM at single dose for COVID-19 immunization. Concomitant medication were not reported. Prior to vaccination, the patient not diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. The patient not-receive any other vaccines within 4 weeks prior to the COVID vaccine. No known allergies.On 11Feb2021 at 03:00 AM patient experienced fever, chills, headache and sore arm. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 1221689
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Terrible diarrhea; patient feels awkward and she going to die; acting very puny; bit of lethargic; This is a spontaneous report from a contactable consumer or other non-health care professional. An 83-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: UNKNOWN) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history included asthma. The patient's concomitant medications were not reported. On an unspecified date, reporter mentioned patient got terrible diarrhea, patient feels awkward and she going to die, she was acting very puny and bit of lethargic. Reporter wanted to know if it was something that could be bothering her four days after or three days after she had the treatment. Reporter also wanted to know if it could be because of the vaccination and how much should they worry about it. Outcome of the events was unknown. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1221690
Sex: F
Age:
State:

Vax Date: 02/04/2021
Onset Date: 02/17/2021
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: exposed to daughter on 17Feb2021 who tested positive for covid on 18Feb2021; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 75 (age unit unknown) old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported) via unknown route on 04Feb2021 at single dose for covid-19 immunisation. The patient is scheduled for second Pfizer COVID vaccine on 25Feb2021. Patient was exposed to daughter on 17Feb2021 who tested positive for COVID on 18Feb2021. Reportedly, patient had no symptoms of COVID but was asking if it's okay to go ahead with her appointment for the second Pfizer COVID vaccine on 25Feb2021. The outcome of the event was unknown. Information on lot number/batch number has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1221691
Sex: M
Age:
State:

Vax Date: 02/18/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: has been exposed to his wife who has been tested positive for COVID after receiving the first dose of Pfizer's COVID vaccine; This is a spontaneous report from a contactable consumer or other non hcp. A male patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 18Feb2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient has been exposed to his wife who has been tested positive for covid after receiving the first dose of pfizers covid vaccine on an unspecified date. The outcome of the event was unknown. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 16Feb2021. The action taken in response to the event(s) for bnt162b2 was not applicable. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1221692
Sex: F
Age:
State: NJ

Vax Date: 02/15/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: 1st dose of the vaccine on 15Feb2021 and tested positive for COVID 3 days later; This is a spontaneous report from a contactable consumer. A female of an unspecified age (age was reported as Age: 66; Unit: Unspecified) received bnt162b2 (COMIRNATY, Lot number: EJ6136), intramuscularly on 15Feb2021 as a single dose as Covid-19 prophylactic vaccination (COVID-19 immunisation). The patient's medical history and concomitant medications were not reported. she received the 1st dose of the vaccine on 15Feb2021 and tested positive for COVID 3 days later. She is asking what should be done with the 2nd dose and when to take it. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1221693
Sex: F
Age:
State:

Vax Date: 02/04/2021
Onset Date:
Rec V Date: 04/17/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Caller mentioned she got the first dose of the Pfizer COVID-19 vaccine on February 4 2021. Her husband got tested positive for COVID last Saturday.; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 04Feb2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Caller mentioned she got the first dose of the Pfizer COVID-19 vaccine on 4Feb2021. Her husband got tested positive for COVID last Saturday. Caller wants to know what's was the efficacy after dose one. Caller wanted to know if she test positive could she receive the vaccine. If she get the vaccine while being positive would that be terminal to her health. Caller asked should she get tested for COVID before receiving the vaccine. Outcome of the event was unknown. Information on lot/ batch has been requested. Follow-up attempts are completed. No further information is expected. .

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm